Evidence map›Paper›PMID 32860071›Full record

ArticlePsychopharmacology2020

Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Shveta V Parekh, Jacqueline E Paniccia, Christina L Lebonville, Donald T Lysle

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Kratom (Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Rapidly GrowingInternational journal of molecular sciences · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shveta V ParekhDepartment of Psychology and Neuroscience, University of North Carolina at Chapel Hill, CB#3270, Chapel Hill, NC, 27599-3270, USA.
Jacqueline E PanicciaDepartment of Psychology and Neuroscience, University of North Carolina at Chapel Hill, CB#3270, Chapel Hill, NC, 27599-3270, USA.
Christina L LebonvilleDepartment of Psychology and Neuroscience, University of North Carolina at Chapel Hill, CB#3270, Chapel Hill, NC, 27599-3270, USA.
Donald T LysleDepartment of Psychology and Neuroscience, University of North Carolina at Chapel Hill, CB#3270, Chapel Hill, NC, 27599-3270, USA. dlysle@email.unc.edu.ORCID http://orcid.org/0000-0001-5404-7910
University of North Carolina at Chapel Hill · US

Funding

Training on Research in Drug AbuseT32DA007244 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Regina M Carelli · 1990 to 2026
$7.6M
Role of IL-1 in Heroin's Immune and Motivational EffectsR01DA034721 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FUCHS LOKENSGARD, RITA A, LYSLE, DONALD T · 2014 to 2018
$1.9M
Neural Immune mechanisms of heroin withdrawal and stressR21DA048241 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LYSLE, DONALD T · 2020 to 2021
$428k
A Role for IL-1Beta in Ethanol Withdrawal-Induced Increase of PTSD-Like PhenotypeR21AA027463 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LYSLE, DONALD T, THIELE, TODD ERIC · 2020 to 2021
$408k
Hippocampal-dependent neural immune interactions regulate heroin-conditioned immunomodulationF31DA047054 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PANICCIA, JACQUELINE ELIZABETH · 2019 to 2020
$74k
NIAAA NIH HHS R21 AA027463NIDA NIH HHS F31 DA047054NIDA NIH HHS R01 DA034721NIDA NIH HHS R21 DA048241NIDA NIH HHS T32 DA007244
6 · The paper itself

Abstract

Converging evidence suggests opioid abuse can increase the incidence and severity of post-traumatic stress disorder (PTSD) in clinical populations. Interestingly, opioid withdrawal alone can produce symptoms similar to those of PTSD. Despite this association, the neural mechanisms underlying the relationship of opioid abuse, withdrawal, and PTSD is poorly understood. Our laboratory has investigated the neurobiological underpinnings of stress-enhanced fear learning (SEFL), an animal model of PTSD-like symptoms. We have previously shown that, in SEFL, a severe footshock induces an increase in dorsal hippocampal (DH) interleukin-1β (IL-1β), and subsequent fear learning is blocked by DH IL-1 receptor antagonism (IL-1RA). Given that opioids and stress engage similar neuroimmune mechanisms, the present experiments investigate whether the same mechanisms drive heroin withdrawal to induce a PTSD-like phenotype. First, we tested the effect of a chronic escalating heroin dose and withdrawal regimen on fear learning and found it produces enhanced future fear learning. Heroin withdrawal also induces a time-dependent, region-specific increase in IL-1β and glial fibrillary acidic protein (GFAP) immunoreactivity within the dentate gyrus of the DH. IL-1β was significantly colocalized with GFAP, indicating astrocytes may be involved in increased IL-1β. Moreover, intra-DH infusions of IL-1RA 0, 24, and 48 h into heroin withdrawal prevents the development of enhanced fear learning but does not alter withdrawal-induced weight loss. Collectively, our data suggests heroin withdrawal is sufficient to produce enhanced fear learning, astrocytes may play a role in heroin withdrawal-induced IL-1β, and DH IL-1 signaling during withdrawal mediates the development of heroin withdrawal-enhanced fear learning.

Indexed as

Analgesics, OpioidAnimalsFearHeroinHippocampusInterleukin-1betaLearningMaleRatsRats, Sprague-DawleySignal TransductionSubstance Withdrawal SyndromeAnalgesics, OpioidHeroinIL1B protein, ratInterleukin-1betaGliaHeroinNeuroimmunologyOpioidPTSDWithdrawal

Identifiers

PMID32860071
PMCPMC7686097
OpenAlexW3082837697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.